STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Inmode Ltd. Stock Price, News & Analysis

INMD Nasdaq

Welcome to our dedicated page for Inmode Ltd. news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode Ltd. stock.

InMode Ltd. (INMD) delivers innovative radiofrequency-based solutions for minimally invasive aesthetic treatments. This news hub provides investors and medical professionals with essential updates on the company's strategic developments, technological advancements, and market leadership in medical aesthetics.

Access real-time announcements including quarterly earnings, product launch details, regulatory milestones, and partnership agreements. Our curated collection features press releases covering facial/body contouring innovations, clinical study results, and intellectual property developments central to INMD's growth strategy.

Key updates include FDA-cleared device announcements, global expansion initiatives, and R&D breakthroughs in RF energy applications. Bookmark this page for verified information on corporate governance changes, manufacturing updates, and industry conference participation directly from InMode's communications team.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.31%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
-
Rhea-AI Summary

InMode Ltd. (INMD) announced the expected release of its first-quarter 2023 financial results on May 2, 2023, before the Nasdaq market opens. Preliminary estimates indicate revenue between $105.7 million and $105.9 million, and non-GAAP earnings per diluted share in the range of $0.50 to $0.51. The company anticipates a non-GAAP gross margin between 83% and 85%. The management team will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors are encouraged to register for the call ahead of time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.13%
Tags
Rhea-AI Summary

InMode Ltd. (NASDAQ: INMD) announced on March 13, 2023, that it does not hold cash or securities at Silicon Valley Bank. The company keeps its cash and non-insured deposits in U.S. money center banks and major Israeli financial institutions. Consequently, InMode does not anticipate any operational impact from the bank's closure. The company will continue to monitor potential effects on its suppliers, vendors, and other partners.

InMode is recognized for its innovative medical technologies, particularly those utilizing radiofrequency (RF) technology, serving various medical fields including plastic surgery and dermatology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none

FAQ

What is the current stock price of Inmode Ltd. (INMD)?

The current stock price of Inmode Ltd. (INMD) is $14.06 as of November 21, 2025.

What is the market cap of Inmode Ltd. (INMD)?

The market cap of Inmode Ltd. (INMD) is approximately 868.5M.
Inmode Ltd.

Nasdaq:INMD

INMD Rankings

INMD Stock Data

868.49M
56.48M
15.35%
59.25%
5.46%
Medical Devices
Healthcare
Link
Israel
Yokne'am